Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.
2.

When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.

Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ.

Crit Care Med. 2006 Nov;34(11):2738-47. Review.

PMID:
16957636
3.
4.

Economic Evaluation of Telemedicine for Patients in ICUs.

Yoo BK, Kim M, Sasaki T, Melnikow J, Marcin JP.

Crit Care Med. 2016 Feb;44(2):265-74. doi: 10.1097/CCM.0000000000001426.

PMID:
26540398
5.

Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.

Hay JW, Smeeding J, Carroll NV, Drummond M, Garrison LP, Mansley EC, Mullins CD, Mycka JM, Seal B, Shi L.

Value Health. 2010 Jan-Feb;13(1):3-7. doi: 10.1111/j.1524-4733.2009.00663.x. Epub 2009 Oct 28.

6.

Over-, under- and misuse of pain treatment in Germany.

Dietl M, Korczak D.

GMS Health Technol Assess. 2011 Apr 19;7:Doc03. doi: 10.3205/hta000094.

7.

Understanding economic outcomes in critical care.

Kahn JM.

Curr Opin Crit Care. 2006 Oct;12(5):399-404. Review.

PMID:
16943716
8.

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators..

Crit Care Med. 2003 Jan;31(1):1-11.

PMID:
12544986
9.
10.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

11.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

12.

[Methods for cost-effectiveness evaluation of intensive care].

Heslet L, Andersen JS, Keiding H.

Ugeskr Laeger. 2007 Feb 19;169(8):721-4. Danish.

PMID:
17313927
13.
14.
15.

An update on cost-effectiveness analysis in critical care.

Shorr AF.

Curr Opin Crit Care. 2002 Aug;8(4):337-43. Review.

PMID:
12386495
16.

A cost-effectiveness analysis of stays in intensive care units.

Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea.

Intensive Care Med. 2001 Jan;27(1):146-53.

PMID:
11280626
17.

Federal and nationwide intensive care units and healthcare costs: 1986-1992.

Halpern NA, Bettes L, Greenstein R.

Crit Care Med. 1994 Dec;22(12):2001-7.

PMID:
7988140
18.
19.

Home treatment for mental health problems: a systematic review.

Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, Wright C.

Health Technol Assess. 2001;5(15):1-139. Review.

20.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

Supplemental Content

Support Center